Quinagolide

Quinagolide
Systematic (IUPAC) name
	N,N-diethyl-N'-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only);
Routes of; administration	Oral
Identifiers
CAS Number	87056-78-8
ATC code	G02CB04
PubChem	CID: 55645
ChemSpider	2343034
UNII	80Q9QWN15M
KEGG	D07217
ChEMBL	CHEMBL290962
Chemical data
Formula	C20H33N3O3S
Molecular mass	395.56 g/mol
	InChI InChI=1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1 ; Key:GDFGTRDCCWFXTG-ZIFCJYIRSA-N ;
(what is this?) (verify)

Quinagolide (Norprolac) is a selective, D₂ receptor agonist that is used for the treatment of elevated levels of prolactin.^[1]

References[edit]

^ Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo, Carolina Di Somma, Rosario Pivonello, Gaetana Cerbone, Gaetano Lombardi, Annamaria Colao (July 2000). "The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas". Clinical Endocrinology 53 (1): 53–60. doi:10.1046/j.1365-2265.2000.01016.x. PMID 10931080.